METHODS TO POTENTIATE INTRAVENOUS ESTRAMUSTINE PHOSPHATE
Estramustine phosphate is an anti-mitotic chemotherapeutic drug with proven efficacy against cancer. The invention describes methods which potentiate the therapeutic benefit of intravenous estramustine phosphate. The invention provides for intravenous estramustine phosphate to be administrated at a...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
23.07.2003
|
Edition | 7 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Estramustine phosphate is an anti-mitotic chemotherapeutic drug with proven efficacy against cancer. The invention describes methods which potentiate the therapeutic benefit of intravenous estramustine phosphate. The invention provides for intravenous estramustine phosphate to be administrated at a high dosage exceeding 1300 mg as a single dose. Efficacious enhancement of estramustine phosphate pharmacokinetics is thereby achieved. Further provided, estramustine phosphate may be intravenously administered for use in combinational regimens with other chemotherapeutic agent. The therapeutic advantages achieved using the intravenous estramustine phosphate formulation are applicable to treatment of a variety of cancers including prostate cancer, breast cancer, lung cancer, colorectal cancer, pancreatic cancer, ovarian cancer, melanoma, and other cancers. |
---|---|
AbstractList | Estramustine phosphate is an anti-mitotic chemotherapeutic drug with proven efficacy against cancer. The invention describes methods which potentiate the therapeutic benefit of intravenous estramustine phosphate. The invention provides for intravenous estramustine phosphate to be administrated at a high dosage exceeding 1300 mg as a single dose. Efficacious enhancement of estramustine phosphate pharmacokinetics is thereby achieved. Further provided, estramustine phosphate may be intravenously administered for use in combinational regimens with other chemotherapeutic agent. The therapeutic advantages achieved using the intravenous estramustine phosphate formulation are applicable to treatment of a variety of cancers including prostate cancer, breast cancer, lung cancer, colorectal cancer, pancreatic cancer, ovarian cancer, melanoma, and other cancers. |
Author | KOPRESKI, MICHAEL, S ASP, BERYL FREDHOLM, BO GUNNARSSON, PER-OLV |
Author_xml | – fullname: GUNNARSSON, PER-OLV – fullname: KOPRESKI, MICHAEL, S – fullname: ASP, BERYL – fullname: FREDHOLM, BO |
BookMark | eNrjYmDJy89L5WSw8HUN8fB3CVYI8VcI8A9x9QvxdAxxVfD0CwlyDHP18w8NVnANBrJ9Q4NDPP1cFQI8_IMDPIBKeBhY0xJzilN5oTQ3g4Kba4izh25qQX58anFBYnJqXmpJvGuAoYGBsamRoaOJMRFKAF-AKmU |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | VERFAHREN ZUR POTENZIERUNG INTRAVENÖS ESTRAMUSTIN PHOSFAT PROCEDES DE POTENTIALISATION DE L'ESTRAMUSTINE PHOSPHATE INTRAVEINEUX |
Edition | 7 |
ExternalDocumentID | EP1003521A4 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_EP1003521A43 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 13:02:21 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French German |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_EP1003521A43 |
Notes | Application Number: EP19990914884 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20030723&DB=EPODOC&CC=EP&NR=1003521A4 |
ParticipantIDs | epo_espacenet_EP1003521A4 |
PublicationCentury | 2000 |
PublicationDate | 20030723 |
PublicationDateYYYYMMDD | 2003-07-23 |
PublicationDate_xml | – month: 07 year: 2003 text: 20030723 day: 23 |
PublicationDecade | 2000 |
PublicationYear | 2003 |
RelatedCompanies | PHARMACIA & UPJOHN COMPANY |
RelatedCompanies_xml | – name: PHARMACIA & UPJOHN COMPANY |
Score | 2.5675237 |
Snippet | Estramustine phosphate is an anti-mitotic chemotherapeutic drug with proven efficacy against cancer. The invention describes methods which potentiate the... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | METHODS TO POTENTIATE INTRAVENOUS ESTRAMUSTINE PHOSPHATE |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20030723&DB=EPODOC&locale=&CC=EP&NR=1003521A4 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1NT8Iw9AXRqDdFjfiVHsxui4xtHR6Iga3LMNm6sEK4EdaWhMsgMuPf920B9KK3pm1eXpu-z74PgGdNqex62jO1kjkaKDbyQepQ0126VHcsSZWsHPpxQqOJ8z5zZw1Y7XNh6jqhX3VxRKQoifRe1vx68-PECurYyu1LvsKp9Vso-oGxt47xxXZtIxj2WcoD7hu-jyMjGaOuWxX-tAbOERxXWnRVZp9Nh1VSyua3RAkv4CRFYEV5CQ1dtODM3zdea8FpvPvvxuGO9LZX0IuZiHiQEcFJygVLxGggGBklYjyYsoRPMsKqBsjxJBOjhJE04lka4ZZrICETfmQiCvPDcecsPSBr30CzWBf6Fkhvacn8VS1kx1IoQ2w0CxxKc0WVpRZa6ja0_wRz98_aPZzX8Wkdz-zaD9AsPz71I8rZMn-qb-gbcUN9fw |
link.rule.ids | 230,309,786,891,25594,76906 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1NT8Iw9AXRiDdFDfi5g9ltkbHR4YEY2Eo2Zd3CCuFGWFsSLoPIjH_ftwXQi96atnl5bfo--z4AnhQhou0ox1BSpGigWMgHiU2MzrJDVMsURIrCoR8y4k_st1lnVoHVPhemrBP6VRZHRIoSSO95ya83P04sr4yt3D6nK5xavw55z9P31jG-2Lale4MejSMvcnXXxZHOxqjrFoU_zb59BMdOUZy30JymgyIpZfNbogzP4SRGYFl-ARWV1aHm7huv1eE03P1343BHettL6IaU-5GXaDzS4ohTxoM-p1rA-Lg_pSyaJBotGiCHk4QHjGqxHyWxj1uuQBtS7voGojA_HHdO4wOy1jVUs3WmGqB1l6ZIX-RCtEyJMsRCs8AmJJVEmnKhhGpC808wN_-sPULN5-FoPgrY-y2clbFqLcdoW3dQzT8-1T3K3Dx9KG_rG3gAgGw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=METHODS+TO+POTENTIATE+INTRAVENOUS+ESTRAMUSTINE+PHOSPHATE&rft.inventor=GUNNARSSON%2C+PER-OLV&rft.inventor=KOPRESKI%2C+MICHAEL%2C+S&rft.inventor=ASP%2C+BERYL&rft.inventor=FREDHOLM%2C+BO&rft.date=2003-07-23&rft.externalDBID=A4&rft.externalDocID=EP1003521A4 |